BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20805128)

  • 1. Expression of MCSP and PRAME in conjunctival melanoma.
    Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Meller D; Zeschnigk M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
    Br J Ophthalmol; 2010 Oct; 94(10):1322-7. PubMed ID: 20805128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic utility of PRAME and p16 in distinguishing nodal nevi from nodal metastatic melanoma.
    See SHC; Finkelman BS; Yeldandi AV
    Pathol Res Pract; 2020 Sep; 216(9):153105. PubMed ID: 32825968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous nevi.
    Holt JB; Sangueza OP; Levine EA; Shen P; Bergman S; Geisinger KR; Creager AJ
    Am J Clin Pathol; 2004 Jan; 121(1):58-63. PubMed ID: 14750241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for conjunctival melanoma metastasis: literature review.
    Missotten GS; de Wolff-Rouendaal D; de Keizer RJ
    Bull Soc Belge Ophtalmol; 2007; (306):23-30. PubMed ID: 18251451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
    Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
    Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL
    Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
    Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U
    J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
    Tuomaala S; Kivelä T
    Ophthalmology; 2004 Apr; 111(4):816-21. PubMed ID: 15051218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic search for the best gene expression markers for melanoma micrometastasis detection.
    Soikkeli J; Lukk M; Nummela P; Virolainen S; Jahkola T; Katainen R; Harju L; Ukkonen E; Saksela O; Hölttä E
    J Pathol; 2007 Oct; 213(2):180-9. PubMed ID: 17891747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric metastases from conjunctival melanoma.
    Cohen VM; Ahmadi-lari S; Hungerford JL
    Melanoma Res; 2007 Aug; 17(4):255-6. PubMed ID: 17625457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
    Kuźbicki L; Gajo B; Chwirot BW
    Melanoma Res; 2006 Jun; 16(3):235-43. PubMed ID: 16718270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological and Prognostic Significance of PRAME Overexpression in Human Cancer: A Meta-Analysis.
    Li J; Yin J; Zhong J; Yang Z; Tang A; Li S
    Biomed Res Int; 2020; 2020():8828579. PubMed ID: 33381588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of interleukin-8 in the initiation and progression of human cutaneous melanoma.
    Gutman M; Even-Sapir E; Merimsky O; Trejo L; Klausner JM; Lev-Chelouche D
    Anticancer Res; 2002; 22(6A):3395-8. PubMed ID: 12530093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival melanoma in the Netherlands: a nationwide study.
    Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-anatomy related antigen expression in melanocytic lesions.
    Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
    J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum.
    Plaza JA; Torres-Cabala C; Evans H; Diwan HA; Suster S; Prieto VG
    Am J Dermatopathol; 2010 Apr; 32(2):129-36. PubMed ID: 20010406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Idiosyncrasies of scalp melanoma.
    Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M
    Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.
    Piras F; Murtas D; Minerba L; Ugalde J; Floris C; Maxia C; Colombari R; Perra MT; Sirigu P
    Histopathology; 2007 Jun; 50(7):835-42. PubMed ID: 17543072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.